Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Juan Balasch

Showing results (81-90 of 119) with videos related to

Pageof 12
Sort By:
Human Reproduction (Oxford, England)|August 31, 2002
alphavbeta3 integrin expression and pinopod formation in normal and out-of-phase endometria of fertile and infertile womenMontserrat Creus, Jaume Ordi, Francisco Fábregues, et al.
Human Reproduction (Oxford, England)|January 11, 2011
Reduced plasma fibrinolytic potential in patients with recurrent implantation failure after IVF and embryo transferM Angeles Martínez-Zamora, Montserrat Creus, Dolors Tassies, et al.
Human Reproduction (Oxford, England)|December 21, 2004
Previous cycle cancellation due to poor follicular development as a predictor of ovarian response in cycles stimulated with gonadotrophin-releasing hormone agonist-gonadotrophin treatmentJoana Peñarrubia, Francisco Fábregues, Dolors Manau, et al.
Fertility and Sterility|March 4, 2008
Protamine 2 precursors (Pre-P2), protamine 1 to protamine 2 ratio (P1/P2), and assisted reproduction outcomeSara de Mateo, Cristina Gázquez, Marta Guimerà, et al.
Journal of Reproductive Immunology|July 3, 2010
Clot lysis time and thrombin activatable fibrinolysis inhibitor in severe preeclampsia with or without associated antiphospholipid antibodiesM Angeles Martínez-Zamora, Dolors Tassies, Francisco Carmona, et al.
Reproductive Biomedicine Online|May 20, 2004
Outcome from consecutive assisted reproduction cycles in patients treated with recombinant follitropin alfa filled-by-bioassay and those treated with recombinant follitropin alfa filled-by-massJuan Balasch, Francisco Fábregues, Joana Peñarrubia, et al.
Human Reproduction (Oxford, England)|March 28, 2003
The effect of different hormone therapies on integrin expression and pinopode formation in the human endometrium: a controlled studyMontserrat Creus, Jaume Ordi, Francisco Fábregues, et al.
Reproductive Biomedicine Online|March 3, 2004
Serum progesterone concentrations on the day of HCG administration cannot predict pregnancy in assisted reproduction cyclesFrancisca Martínez, Buenaventura Coroleu, Elisabeth Clua, et al.
Reproductive Biomedicine Online|March 3, 2004
Initial analysis of variability among basal hormone biomarkers of ovarian reserveJoana Peñarrubia, Francisco Fábregues, Dolors Manau, et al.
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|November 10, 2009
Thrombin activatable fibrinolysis inhibitor and clot lysis time in pregnant patients with antiphospholipid syndrome: relationship with pregnancy outcome and thrombosisMaria Angeles Martinez-Zamora, Dolors Tassies, Francisco Carmona, et al.
Pageof 12

Showing results (81-90 of 119) with videos related to

Sort By:
Pageof 12
Human Reproduction (Oxford, England)|August 31, 2002
alphavbeta3 integrin expression and pinopod formation in normal and out-of-phase endometria of fertile and infertile womenMontserrat Creus, Jaume Ordi, Francisco Fábregues, et al.
Human Reproduction (Oxford, England)|January 11, 2011
Reduced plasma fibrinolytic potential in patients with recurrent implantation failure after IVF and embryo transferM Angeles Martínez-Zamora, Montserrat Creus, Dolors Tassies, et al.
Human Reproduction (Oxford, England)|December 21, 2004
Previous cycle cancellation due to poor follicular development as a predictor of ovarian response in cycles stimulated with gonadotrophin-releasing hormone agonist-gonadotrophin treatmentJoana Peñarrubia, Francisco Fábregues, Dolors Manau, et al.
Fertility and Sterility|March 4, 2008
Protamine 2 precursors (Pre-P2), protamine 1 to protamine 2 ratio (P1/P2), and assisted reproduction outcomeSara de Mateo, Cristina Gázquez, Marta Guimerà, et al.
Journal of Reproductive Immunology|July 3, 2010
Clot lysis time and thrombin activatable fibrinolysis inhibitor in severe preeclampsia with or without associated antiphospholipid antibodiesM Angeles Martínez-Zamora, Dolors Tassies, Francisco Carmona, et al.
Reproductive Biomedicine Online|May 20, 2004
Outcome from consecutive assisted reproduction cycles in patients treated with recombinant follitropin alfa filled-by-bioassay and those treated with recombinant follitropin alfa filled-by-massJuan Balasch, Francisco Fábregues, Joana Peñarrubia, et al.
Human Reproduction (Oxford, England)|March 28, 2003
The effect of different hormone therapies on integrin expression and pinopode formation in the human endometrium: a controlled studyMontserrat Creus, Jaume Ordi, Francisco Fábregues, et al.
Reproductive Biomedicine Online|March 3, 2004
Serum progesterone concentrations on the day of HCG administration cannot predict pregnancy in assisted reproduction cyclesFrancisca Martínez, Buenaventura Coroleu, Elisabeth Clua, et al.
Reproductive Biomedicine Online|March 3, 2004
Initial analysis of variability among basal hormone biomarkers of ovarian reserveJoana Peñarrubia, Francisco Fábregues, Dolors Manau, et al.
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|November 10, 2009
Thrombin activatable fibrinolysis inhibitor and clot lysis time in pregnant patients with antiphospholipid syndrome: relationship with pregnancy outcome and thrombosisMaria Angeles Martinez-Zamora, Dolors Tassies, Francisco Carmona, et al.
Pageof 12